D69.6

Thrombocytopenia, unspecified

Thrombocytopenia is a hematological condition defined by a platelet count below the normal lower limit, typically 150,000 cells per microliter. Platelets (thrombocytes) are essential for primary hemostasis; they adhere to sites of vascular injury and aggregate to form a mechanical plug. When platelet counts drop significantly, the body's ability to form clots is impaired, leading to increased bleeding risks. The condition occurs through three primary pathophysiological mechanisms: decreased platelet production in the bone marrow (often due to marrow failure or infiltration), increased peripheral destruction (which may be immune-mediated or due to consumption), or sequestration within an enlarged spleen. D69.6 is the diagnostic code utilized when the specific etiology of the low platelet count is not further specified or is currently under investigation. Clinical risk increases as the platelet count declines; while patients may be asymptomatic at counts above 50,000/uL, the risk of spontaneous life-threatening bleeding, such as intracranial hemorrhage, rises sharply when counts fall below 10,000 to 20,000/uL.

Clinical Symptoms

  • Petechiae (pinpoint round red/purple spots)
  • Purpura (larger purple/brown bruises)
  • Ecchymosis (easy or excessive bruising)
  • Epistaxis (frequent nosebleeds)
  • Gingival bleeding (bleeding gums)
  • Menorrhagia (abnormally heavy or prolonged menstrual bleeding)
  • Prolonged bleeding from minor cuts or dental work
  • Hematochezia (blood in stool)
  • Hematuria (blood in urine)
  • Fatigue
  • Splenomegaly (sensation of fullness in the left upper abdomen)
  • Spontaneous internal hemorrhage in severe cases

Common Causes

  • Bone marrow failure syndromes (e.g., aplastic anemia)
  • Leukemia, lymphoma, or other metastatic cancers infiltrating the marrow
  • Myelodysplastic syndromes
  • Viral infections including HIV, Hepatitis C, EBV, and Cytomegalovirus
  • Chemotherapy and radiation therapy
  • Drug-induced immune thrombocytopenia (e.g., heparin, quinine, sulfonamides)
  • Immune thrombocytopenic purpura (ITP)
  • Alcohol abuse (direct toxic effect on marrow)
  • Vitamin B12 and folate deficiencies
  • Splenic sequestration due to portal hypertension or cirrhosis
  • Disseminated intravascular coagulation (DIC)
  • Thrombotic thrombocytopenic purpura (TTP)
  • Hemolytic uremic syndrome (HUS)

Documentation & Coding Tips

Distinguish between primary and secondary causes to avoid unspecified coding.

Example: Patient presents with a platelet count of 45,000. History is notable for chronic Hepatitis C with associated cirrhosis and splenomegaly. Documentation clarifies the thrombocytopenia is secondary to splenic sequestration rather than primary immune destruction. ICD-10-CM D69.59 (Other secondary thrombocytopenia) is used instead of D69.6 to reflect the underlying etiology and higher clinical severity.

Billing Focus: Identify the underlying cause (e.g., drug-induced, post-transfusion, or due to liver disease) to support higher specificity levels.

Document the acuity and duration of the condition to clarify if it is a chronic or acute event.

Example: A 65-year-old male with a 2-year history of chronic refractory thrombocytopenia presents for routine follow-up. Current platelet count is stable at 82,000. Plan includes continuing Romiplostim. Documentation notes this as a chronic, stable condition requiring ongoing management of moderate severity.

Billing Focus: Documentation of chronicity supports medical necessity for repeat CBC monitoring and specialized hematology consults.

Specify any causative agents, particularly medications like Heparin or Chemotherapy.

Example: Patient currently on prophylactic Heparin for DVT prophylaxis. Platelet count dropped 50 percent from baseline on day 4. Evaluation confirms Heparin-Induced Thrombocytopenia (HIT) type 2. Heparin discontinued immediately; Argatroban started. Documentation specifies HIT rather than unspecified thrombocytopenia.

Billing Focus: Causative agent identification allows for the use of D75.82 (Heparin-induced thrombocytopenia) which is more specific than D69.6.

Link thrombocytopenia to manifestations like petechiae, ecchymosis, or active hemorrhage.

Example: Patient presents with epistaxis and diffuse petechiae on lower extremities. Platelet count is 12,000. Assessment: Acute symptomatic thrombocytopenia with active bleeding. Plan: Admit for IVIG and steroid pulse therapy. Clinical note links the low count to the physical findings.

Billing Focus: Linking symptoms (e.g., R23.3 Spontaneous ecchymosis) to the diagnosis justifies intensive inpatient management levels.

Explicitly state if the thrombocytopenia is a complication of pregnancy or the postpartum period.

Example: Patient at 34 weeks gestation with new-onset thrombocytopenia (95,000). BP is normal, ruling out HELLP syndrome. Documented as Gestational Thrombocytopenia. Management: Close observation through delivery. Documentation avoids the generic D69.6 in favor of O99.113.

Billing Focus: Pregnancy-specific codes (Chapter 15) must be prioritized over Chapter 3 codes when the condition is pregnancy-related.

Relevant CPT Codes

Related Diagnoses

Hierarchy